Last reviewed · How we verify
Anaprazole Sodium enteric-coated tablet
Anaprazole Sodium enteric-coated tablet is a Small molecule drug developed by Sihuan Pharmaceutical Holdings Group Ltd.. It is currently FDA-approved.
Anaprazole Sodium enteric-coated tablets are used to treat Helicobacter pylori infections, as well as conditions in healthy volunteers, individuals with hepatic insufficiency, renal insufficiency, and the elderly. The mechanism of action of Anaprazole Sodium is not specified in the provided facts, but it is used in combination with bismuth-containing quadruple therapy for Helicobacter pylori eradication.
At a glance
| Generic name | Anaprazole Sodium enteric-coated tablet |
|---|---|
| Sponsor | Sihuan Pharmaceutical Holdings Group Ltd. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations (PHASE4)
- Drug-drug Interaction Study of Rifampin and Anaprazole Sodium (PHASE4)
- A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis (PHASE2)
- A Multiple Ascending High Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects (PHASE1)
- A Single Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects (PHASE1)
- A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects (PHASE1)
- Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anaprazole Sodium enteric-coated tablet CI brief — competitive landscape report
- Anaprazole Sodium enteric-coated tablet updates RSS · CI watch RSS
- Sihuan Pharmaceutical Holdings Group Ltd. portfolio CI
Frequently asked questions about Anaprazole Sodium enteric-coated tablet
What is Anaprazole Sodium enteric-coated tablet?
Who makes Anaprazole Sodium enteric-coated tablet?
What development phase is Anaprazole Sodium enteric-coated tablet in?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing